Clinically isolated syndromes suggestive of multiple sclerosis: An optical coherence tomography study

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Oreja Guevara, Celia ^a   Noval, Susana ^a   Alvarez Linera, Juan ^b   Gabaldón, Laura ^c   Manzano, Beatriz ^a   Chamorro, Beatriz ^a   Diez Tejedor, Exuperio ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL RUBER INTERNACIONAL   (Spain)

^c Hospital de Denia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN STEM INJURY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICALLY ISOLATED SYNDROMES SUGGESTIVE OF MULTIPLE SCLEROSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PREDICTION; PROSPECTIVE STUDY; RETINA NERVE CELL; SENSITIVITY AND SPECIFICITY; SENSORY DYSFUNCTION; SPINAL CORD DISEASE; ADOLESCENT; DEMYELINATING DISEASE; FOLLOW UP; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBER; PATHOLOGY; RETINA GANGLION CELL;

ADOLESCENT; ADULT; AXONS; CROSS-SECTIONAL STUDIES; DEMYELINATING DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE FIBERS; PROSPECTIVE STUDIES; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84858693612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033907     Document Type: Article

References (42)

1. Optic neuritis study group (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65: 727-732.
2. Brex PA, Miszkiel KA, O'Riordan JI, Plant GT, Moseley IF, et al. (2001) Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J Neurol Neurosurg Psychiatry 70: 390-393.
3. Cole SR, Beck RW, Moke PS, Kaufman DI, Tourtellotte WW, (1998) The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Optic Neuritis Study Group. Neurology 51: 885-887.
4. Druschky A, Heckmann JG, Claus D, Katalinic A, Druschky KF, et al. (1999) Progression of optic neuritis to multiple sclerosis: an 8-year follow-up study. Clin Neurol Neurosurg 101: 189-192 S0303846799000451 [pii].
5. Jacobi C, Hahnel S, Martinez-Torres F, Rieger S, Juttler E, et al. (2008) Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time. Eur J Neurol 15: 1359-1364.
6. Jin YP, de Pedro-Cuesta J, Huang YH, Soderstrom M, (2003) Predicting multiple sclerosis at optic neuritis onset. Mult Scler 9: 135-141.
7. Masjuan J, Alvarez-Cermeno JC, Garcia-Barragan N, Diaz-Sanchez M, Espino M, et al. (2006) Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology 66: 576-578 66/4/576 [pii];10.1212/01.wnl.0000198253.35119.83 [doi].
8. Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, et al. (2004) Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 61: 217-221 10.1001/archneur.61.2.217 [doi];61/2/217 [pii].
9. O'Riordan JI, Thompson AJ, Kingsley DP, MacManus DG, Kendall BE, et al. (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 121: 495-503.
10. Tintore M, Rovira A, Rio J, Nos C, Grive E, et al. (2006) Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 67: 968-972.
11. Tintore M, Rovira A, Rio J, Tur C, Pelayo R, et al. (2008) Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 70: 1079-1083 01.wnl.0000280576.73609.c6 [pii];10.1212/01.wnl.0000280576.73609.c6 [doi].
12. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231 10.1002/ana.410130302 [doi].
14. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846 10.1002/ana.20703 [doi].
15. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, et al. (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278-285 10.1056/NEJM199801293380502 [doi].
16. Filippi M, Bozzali M, Rovaris M, Gonen O, Kesavadas C, et al. (2003) Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126: 433-437.
17. Rocca MA, Mezzapesa DM, Falini A, Ghezzi A, Martinelli V, et al. (2003) Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 18: 847-855 S1053811903000430 [pii].
18. Wattjes MP, Harzheim M, Lutterbey GG, Bogdanow M, Schild HH, et al. (2008) High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria. J Neurol 255: 56-63 10.1007/s00415-007-0666-9 [doi].
19. Chen HY, Wang TH, Lee YM, Hung TJ, (2005) Retinal nerve fiber layer thickness measured by optical coherence tomography and its correlation with visual field defects in early glaucoma. J Formos Med Assoc 104: 927-934.
20. Kim JS, Ishikawa H, Sung KR, Xu J, Wollstein G, et al. (2009) Retinal nerve fibre layer thickness measurement reproducibility improved with spectral domain optical coherence tomography. Br J Ophthalmol 93: 1057-1063 bjo.2009.157875 [pii];10.1136/bjo.2009.157875 [doi].
21. Noval S, Contreras I, Rebolleda G, Munoz-Negrete FJ, (2007) Optical coherence tomography in optic neuritis. Ophthalmology 114: 200.
22. Noval S, Contreras I, Rebolleda G, Munoz-Negrete FJ, (2006) Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scand 84: 790-794.
23. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, et al. (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59: 963-969.
24. Trip SA, Schlottmann PG, Jones SJ, Li WY, Garway-Heath DF, et al. (2006) Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 31: 286-293.
25. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, et al. (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 58: 383-391.
26. Gundogan FC, Demirkaya S, Sobaci G, (2007) Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?-A structural and functional evaluation. Invest Ophthalmol Vis Sci 48: 5773-5781.
27. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, et al. (2007) Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 69: 2085-2092.
28. Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J, et al. (2008) Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 14: 609-614.
29. Smith CH, (2005) Optic neuritis. In: Miller NRNN, editors. Walhs & Hoyt Clinical Neuro-ophthalmology Philadelphia, USA Lipincott Williams & Willians pp. 293-347.
30. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
31. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059-2069.
32. Keltner JL, Johnson CA, Spurr JO, Beck RW, (1993) Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 111: 231-234.
33. Noval S, Contreras I, Rebolleda G, Munoz-Negrete FJ, (2006) Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scand 84: 790v794.
34. Pro MJ, Pons ME, Liebmann JM, Ritch R, Zafar S, et al. (2006) Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci 250: 114-119.
35. Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, et al. (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113: 324-332.
36. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, et al. (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 40: 2520-2527.
37. Savini G, Bellusci C, Carbonelli M, Zanini M, Carelli V, et al. (2006) Detection and quantification of retinal nerve fiber layer thickness in optic disc edema using stratus OCT. Arch Ophthalmol 124: 1111-1117.
38. Contreras I, Noval S, Rebolleda G, Munoz-Negrete FJ, (2007) Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography. Ophthalmology 114: 2338-2344.
39. Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, et al. (2008) An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 131: 277-287.
40. Wattjes MP, Harzheim M, Lutterbey GG, Bogdanow M, Schmidt S, et al. (2008) Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology 50: 123-129 10.1007/s00234-007-0325-y [doi].
41. Outteryck O, Zephir H, Defoort S, Bouyon M, Debruyne P, et al. (2009) Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss. Arch Neurol 66: 1373-1377 66/11/1373 [pii];10.1001/archneurol.2009.265 [doi].
42. Rojas JI, Patrucco L, Cristiano E, (2010) Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis. J Neurol 257: 1188-1191 10.1007/s00415-010-5490-y [doi].